Trade Summary

4 days ago, Sanofi, serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 300,000 shares at $17.00 per share, for a total transaction value of $5,100,000.00. Following this transaction, Sanofi now holds 1,082,855 shares of ATTO.

This purchase represents a 38.32% increase in Sanofi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 3:45 PM ET, 1 day after the trade was made.